Characterization of the actin filament capping state in human erythrocyte ghost and cytoskeletal preparations.
The narrow Gaussian-length-distribution of actin filaments forming the cytoskeleton of the human erythrocyte indicates the existence of strict mechanisms for length determination and maintenance. A similar regulation is achieved in striated muscle by the capping of both the ends of the thin filaments, which consequently prevents monomer exchange. However, the ability of erythroid cytoskeletal preparations to nucleate actin polymerization has led to the proliferation of the idea that at least the barbed ends of the actin filaments are uncapped. The mechanism by which the length of the filaments is thus maintained has been left open to debate. In an effort to resolve any doubt regarding length-maintenance in human erythrocytes we have characterized the capping state of the actin filaments in a number of different ghost and cytoskeletal preparations. Under conditions of sufficiently high bivalent-cation concentration the actin filaments retain functional caps at both the barbed and pointed ends. Hence filament capping at both ends prevents redistribution of the actin monomer in a similar manner to that proposed for the thin filaments of striated muscle. Actin filament uncapping is apparently caused by the centrifugal shearing stress imposed during ghost preparation. The uncapping is more pronounced when the bivalent-cation concentration is reduced or when the membrane is removed by detergents. The effects of bivalent cations seem to be mediated through the erythroid protein spectrin, consistent with the hypothesis of Wallis et al. [Wallis, Babitch and Wenegieme (1993) Biochemistry 32, 5045--5050] that the ability of spectrin to resist shearing stress is dependent on the degree of bound bivalent cations.
Kuhlman
P A
PA
Department of Biochemistry, Adrian Building, Leicester University, University Road, Leicester LE1 7RH, UK. pak2@le.ac.uk
D000199:Actins / Q000737:chemistry* / Q000378:metabolism*; D002412:Cations; D003599:Cytoskeleton / Q000737:chemistry / Q000378:metabolism*; D003902:Detergents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004910:Erythrocyte Membrane / Q000378:metabolism*; D006801:Humans; D008274:Magnesium / Q000494:pharmacology; D018482:Muscle, Skeletal / Q000378:metabolism; D011721:Pyrenes / Q000378:metabolism; D013314:Stress, Mechanical; D013997:Time Factors
D000199:Actins; D002412:Cations; D003902:Detergents; D011721:Pyrenes; C030984:pyrene; D008274:Magnesium